FICARRA, Rita
 Distribuzione geografica
Continente #
EU - Europa 5.538
NA - Nord America 4.477
AS - Asia 2.686
SA - Sud America 836
AF - Africa 74
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.623
Nazione #
US - Stati Uniti d'America 4.423
RU - Federazione Russa 2.566
SG - Singapore 1.198
CN - Cina 834
BR - Brasile 740
IE - Irlanda 735
SE - Svezia 611
DE - Germania 438
UA - Ucraina 434
HK - Hong Kong 301
FI - Finlandia 223
GB - Regno Unito 178
FR - Francia 158
VN - Vietnam 82
IT - Italia 76
IN - India 75
AR - Argentina 30
CA - Canada 29
TR - Turchia 27
PL - Polonia 26
ZA - Sudafrica 24
BD - Bangladesh 23
EC - Ecuador 22
IQ - Iraq 22
IR - Iran 20
MX - Messico 20
ES - Italia 18
MA - Marocco 15
PK - Pakistan 15
NL - Olanda 13
UZ - Uzbekistan 13
VE - Venezuela 12
CI - Costa d'Avorio 10
CO - Colombia 10
ID - Indonesia 10
BE - Belgio 9
CZ - Repubblica Ceca 9
JP - Giappone 9
TN - Tunisia 8
AT - Austria 7
PE - Perù 7
AU - Australia 6
AZ - Azerbaigian 6
LV - Lettonia 6
CL - Cile 5
IL - Israele 5
KE - Kenya 5
NP - Nepal 5
OM - Oman 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
MY - Malesia 4
PH - Filippine 4
RO - Romania 4
RS - Serbia 4
SA - Arabia Saudita 4
AL - Albania 3
CH - Svizzera 3
EG - Egitto 3
KZ - Kazakistan 3
LT - Lituania 3
MD - Moldavia 3
AM - Armenia 2
AO - Angola 2
BY - Bielorussia 2
ET - Etiopia 2
EU - Europa 2
GR - Grecia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
PY - Paraguay 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CR - Costa Rica 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MK - Macedonia 1
MN - Mongolia 1
NO - Norvegia 1
NR - Nauru 1
SN - Senegal 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 13.623
Città #
Jacksonville 817
Moscow 817
Dublin 735
Singapore 582
Chandler 462
Ashburn 450
Nyköping 362
Dallas 329
Hong Kong 300
Beijing 258
San Jose 156
Munich 145
Dearborn 139
Cambridge 122
Princeton 122
Medford 115
The Dalles 111
Lauterbourg 108
Des Moines 96
Los Angeles 89
Boardman 88
Buffalo 60
São Paulo 60
Helsinki 58
Tianjin 55
Jinan 49
Ann Arbor 47
Lancaster 45
Guangzhou 39
Ho Chi Minh City 38
Woodbridge 37
New York 36
Wilmington 36
Turku 33
Shenyang 28
Redondo Beach 27
San Mateo 24
Augusta 23
Rio de Janeiro 21
Warsaw 21
Belo Horizonte 20
Houston 20
Nanjing 20
Atlanta 19
Hangzhou 19
Frankfurt am Main 18
Montreal 18
Chennai 17
Nanchang 17
Bremen 16
Brooklyn 16
Ardabil 15
Brasília 15
Leawood 15
Orem 15
Campinas 14
Haikou 13
Pune 13
Phoenix 12
Santa Clara 12
Tashkent 12
Hebei 11
Mumbai 11
Ningbo 11
Seattle 11
Shanghai 11
Abidjan 10
Chicago 10
Guayaquil 10
London 10
Manchester 10
Poplar 10
Porto Alegre 10
Shenzhen 10
Taizhou 10
Brussels 9
Curitiba 9
Denver 9
Hanoi 9
Hyderabad 9
Johannesburg 9
Mexico City 9
Rome 9
Elk Grove Village 8
Fortaleza 8
Fuzhou 8
Goiânia 8
Monmouth Junction 8
Norwalk 8
Saint Petersburg 8
Salvador 8
Tokyo 8
Washington 8
Zhengzhou 8
Amsterdam 7
Baghdad 7
Boston 7
Brno 7
Manaus 7
Messina 7
Totale 7.823
Nome #
Fast drug stability determination by LC variable-parameter kinetic experiments 263
Anticonvulsant agent: enhancement of physicochemical properties 195
An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidate 189
Combined effect of pH and polysorbates with cyclodextrins on solubilization of naringenin 177
ANALYSES AND DETERMINATION OF LONIDAMINE RELEASE FROM PHARMACEUTICAL FORMULATION. 175
BETA-BLOCKERS CHARACTERIZATION BY UV-VIS ABSORPTION AND REFLECTIVITY IN DIFFERENT CHEMICAL ENVIRONMENTS 173
A novel HPLC method for the determination of mitoxantrone in pharmaceutical formulations. 171
Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigation 170
ANALYSIS OF PYRROLIDONIC COMPOUNDS AS POTENTIAL ANTIOXIDANT. 170
Comparative photodegradation studies on 3-hydroxyflavone: influence of different media, pH and light sources 167
A STUDY OF THE INCLUSION COMPLEX OF ATENOLOL WITH BETA-CYCLODEXTRIN 165
Analytical profile and release of lonidamine from pharmaceutical formulation 165
COMBINED EFFECT OF pH AND CYCLODEXTRINS ON SOLUBILIZATION OF NARINGENIN 164
CORDIA FRANCISCI, C, MARTINICENSIS, C. MYXA, C. SERRATIFOLIA AND C. ULMIFOLIA LEAVES AS NEW SOURCES OF RUTIN: ANALGESIC AND ANTI-INFLAMMATORY ACTIVITY. 164
Synthesis, resolution, stereochemistry, and molecular modeling of (R)- and (S)-2-acetyl-1-(4 '-chlorophenyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline AMPAR antagonists 163
COMPARATIVE PHOTODEGRADATION STUDIES: INFLUENCE OF DIFFERENT MEDIA AND LIGHT SOURCES 157
AN EXPERIMENTAL DESIGN METHODOLOGY APPLIED TO THE CHIRAL SEPARATION OF A NON-STEROIDAL ANTI-INFLAMMATORY DRUG CANDIDATE 156
CHROMATOGRAPHIC INVESTIGATIONS ON BROTIZOLAM 154
Cromatografia liquida ad alta efficienza nell'analisi farmaceutica: separazione e determinazione di una miscela diuretica-antipertensiva 153
ENANTIOSEPARATION AND COMPLEXATION STUDIES ON 2,3-BENZODIAZEPINES 153
The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assays 152
ANALISI DI FLUNARIZINA BICLORIDRATO IN FORME FARMACEUTICHE MEDIANTE CROMATOGRAFIA LIQUIDA AD ALTA PRESSIONE 150
Optimization of a LC method for the enantio separation of a non-competitive glutamate receptor antagonist, by experimental design methodology 150
BROTIZOLAM: ANALISI E DETERMINAZIONE MEDIANTE TECNICHE CROMATOGRAFICHE. 150
CONFORMATIONAL SEARCH OF PHENYL SUBSTITUTED GAMMA-LACTAMIC DERIVATIVES. 150
Direct separation of the enantiomers of reboxetine by liquid chromatography on different cellulose- and amylose-based chiral stationary phases 147
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex 142
RUTIN INCLUSION SYSTEMS WITH ALFA AND BETA-CYCLODEXTRINS: CIRCULAR DICHROISM, UV ABSORPTION SPECTROSCOPY AND ANTIOXIDANT ACTIVITY STUDIES 142
SEPARAZIONE E DETERMINAZIONE MEDIANTE HPLC IN FASE INVERSA DI DERIVATI DEL 2-FENILCROMONE E DELL'ACIDO CLOROGENICO DA ESTRATTI DI CRATAEGUS OXYACANTHA L. 141
OPTIMIZED ENANTIOSELECTIVE HPLC METHOD FOR THE ANALYSIS OF TETRAHYDROISOQUINOLINES 139
SPECTROSCOPIC INVESTIGATION OF INCLUSION COMPLEX OF 9-FLUORENONIC DERIVATIVE WITH (2-HYDROXYPROPYL)-BETA-CYD 135
INCLUSION COMPLEXES OF SOME FLAVANONES AND THEIR GLYCOSIDES WITH MODIFIED BETA-CYLODEXTRINS 133
Determination of fludarabine in a pharmaceutical formulation by LC 133
CARATTERIZZAZIONE DI FARMACI POLIMORFI:TERFENADINA 132
Study of the extraction procedure by experimental design and validation of a LC method for determination of flavonoids in Citrus bergamia juice 131
HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY. SEPARATION AND IDENTIFICATION OF FLAVONOIDS IN CRATAEGUS OXYACANTHA L. Note IV. Apigenin, Apigenin-7-glucoside, Luteolin, Luteolin-3',7-diglucoside 121
Effects of alpha and beta-cyclodextrin complexation on the physico-chemical properties and antioxidant activity of some 3-hydroxyflavones 121
MOLECULAR MODELING OF ENANTIOSELECTIVE RECOGNITION BETWEEN GAMMA-LACTAMIC DERIVATIVES AND CHIRALCEL OD CHIRAL STATIONARY PHASE. 119
Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin 119
Study of the inclusion complex of atenolol with beta- cyclodextrins 119
Selective reversed-phase liquid chromatography method for the kinetic investigation of 3-hydroxyflavone photostability 118
Photochemistry of flavonoids. Solvent effect on photochemical behaviour of 3-hydroxyflavone. 117
ISOFLAVONES AND CYCLODEXTRINS: EVIDENCES OF COMPLEXATION BY COMPLEMENTARY SPECTROSCOPIC TECHNIQUES 116
TECNICHE CHEMOMETRICHE PER L'OTTIMIZZAZIONE DI METODOLOGIE STRUMENTALI IN ANALISI FARMACEUTICA 115
Determinazione del trans-1-bis(4-fluorofenil)metil-4-(3-fenil-2-propenil)piperazina dicloridrato mediante HPLC 114
The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin 112
Cromatografia liquida nell'analisi farmaceutica: determinazione nelle compresse della famotidina, nuovo H2-antagonista 111
Dosaggio mediante HPLC di atenololo e clortalidone associati in forme farmaceutiche 111
CROMATOGRAFIA LIQUIDA NELL'ANALISI FARMACEUTICA: SEPARAZIONE E DETERMINAZIONE DI FAMOTIDINA, NUOVO H2-ANTAGONISTA 108
DIRECT ENANTIOMERIC SEPARATION OF REBOXETINE BY LIQUID CHROMATOGRAPHY USING DIFFERENT CELLULOSE AND AMYLOSE BASED CHIRAL STATIONARY PHASES 108
Diastereo-enantioseparation of N-Acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives on cellulose chiral stationary phases 104
Solid-state study of polymorphic drugs: carbamazepine 104
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND DIFFUSE REFLECTANCE SPECTROSCOPY OF FLAVONOIDS IN CRATEGUS-OXYACANTHA L .3. ANALYSIS OF 2-PHENYL-CHROMAN DERIVATIVES AND CAFFEIC ACID 103
STRUCTURAL AND CONFORMATIONAL STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN COMPLEXES 102
PROFILI TEMPERATURA-VELOCITA' DA CINETICHE POLARIMETRICHE A TEMPERATURA VARIABILE 102
Ring opening of carboxy-substituted isoxazolidines: Synthesis of lactones and alpha-hydroxy-gamma-lactams 102
PHARMACEUTICAL APPLICATION OF BETA-CYCLODEXTRIN: INCLUSION COMPLEXES WITH BETA-BLOCKERS 101
FLUORIMETRIC STUDY OF b-BLOCKERS/b-CYCLODEXTRINS INCLUSION COMPLEXES 100
PHOTODEGRADATION STUDY ON 3-HYDROXYFLAVONE BY HPLC. 100
METAL-COMPLEXES OF BENZODIAZEPINES . PART 2. THE REACTION OF 1,4- BENZODIAZEPINES WITH HALIDE-BRIDGED COMPLEXES OF PALLADIUM(II) [PD2X4(PPRN3)2] (X = CL OR I) 100
Sensitive and specific determination of epirubicin and epirubicinol by HPLC. 100
FORCE FIELD COMPARISONS AND CONFORMATIONAL ANALYSIS OF STRUCTURES INTERESTING IN PHARMACEUTICAL RESEARCH. 99
Diastereo-enantioseparation of novel gamma-lactamic derivatives on cellulose chiral stationary phases 97
Raman spectroscopy in variable-parameter kinetics for drug stability evaluation 97
ENANTIOMERIC SEPARATION BY HPLC OF FLAVANONES AND FLAVANS WITH ANTIOXYDANT ACTIVITY. 97
HYDRATATION EFFECT ON THE MICELLAR STRUCTURE OF TRI-BLOCK COPOLYMER IN WATER (VISCOELASTIC RESULTS). 97
MODIFIED CYCLODEXTRINS IN THE SOLUBILIZATION OF SOME PHYTOESTROGENS 96
HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF FLAVONOIDS IN CRATAEGUS-OXYACANTHA L .4. REVERSED-PHASE HIGH-PRESSURE LIQUID- CHROMATOGRAPHY IN FLOWER, LEAF AND BUD EXTRACTIVES OF CRATAEGUS-OXYACANTHA L 96
VALIDATION OF A LIQUID CROMATOGRAPHIC METHOD FOR THE ANALYSIS OF ZAFIRLUKAST IN A PHARMACEUTICAL FORMULATION 95
VALIDATION OF A LC METHOD FOR THE ANALYSIS OF OXALIPLATIN IN A PHARMACEUTICAL FORMULATION USING EXPERIMENTAL DESIGN 95
UV-vis and FTIR-ATR spectroscopic techniques to study the inclusion complexes of genistein with beta-cyclodextrins 95
FAST DETERMINATION OF DRUG STABILITY BY HPLC VARIABLE-PARAMETER KINETIC EXPERIMENTS 94
STRUCTURAL AND THERMODYNAMIC STUDY OF BETA-BLOCKERS/BETA-CYCLODEXTRIN INCLUSION COMPLEXES 94
IMPROVEMENT OF FLAVONOIDS DISSOLUTION PROPERTIES BY COMPLEXATION WITH BETA-CYCLODEXTRIN 94
Isolation and characterization of Guiera senegalensis J.F.Gmel. active principles. 94
Dosaggio HPLC della roxatidina, prove di stabilità e rilascio da formulazioni farmaceutiche. 94
SIMULTANEOUS DETERMINATION OF METAPROLOL AND HYDROCLOROTHIAZIDE IN TWO COMPONENT TABLET FORMULATIONS BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY 93
Variable-Parameter Kinetics: Application in the Pharmaceutical Field 93
STUDIO COMPARATIVO DI RISOLUZIONE ENANTIOMERICA DI NUOVI DERIVATI 2,3-BENZODIAZEPINICI AD ATTIVITA' ANTICONVULSIVANTE SU FASI STAZIONARIE CHIRALI DI NATURA POLISACCARIDICA. 93
MODELLO DI INTERAZIONE SELECTORS-SELCTANDS NEL PROCESSO DI DISCRIMINAZIONE CHIRALE. 92
USE OF DIFFERENT CYCLODEXTRINS AS SOLUBILIZING AGENTS 91
SOLUBILIZATION OF NARINGENIN BY COMBINED CONTROL OF SURFACTANT AND CYCLODEXTRIN 90
STRUCTURE OF BETA-BLOCKERS/BETA-CYCLODEXTRIN INCLUSION COMPLEX BY NMR, X-RAY AND DSC INVESTIGATION 90
HPLC-DAD AND TLC OF FLAVONOIDS FROM LEAF EXTRACTIVES OF GENUS CORDIA. 90
LC/MS SELECTIVE SCREENING OF SOME BETA-BLOCKERS IN HUMAN URINE SAMPLES AND ITS POTENTIAL USE IN DOPING CONTROL 89
HPLC DETERMINATION OF FLAVONOIDS CONTENT IN BERGAMOT JUICE 88
ENANTIOMERIC RESOLUTION: HPLC ON CHIRAL STATIONARY PHASE OF ANTI-HIV AGENTS. 88
Validation of a LC method for the analysis of zafirlukast in a pharmaceutical formulation 88
Risoluzione cromatografica di gamma-lattami su fasi stazionarie chirali a base polisaccaridica. 87
STUDY OF THE EXTRACTION PROCEDURE BY EXPERIMENTAL DESIGN AND VALIDATION OF A LC METHOD FOR DETERMINATION OF FLAVONOIDS IN CITRUS BERGAMIA JUICE 86
HPLC ANALYSIS OF OLEUROPEIN AND SOME FLAVONOIDS IN LEAF AND BUD OF OLEA-EUROPAEA L 85
The enhancement of isoflavones water solubility by complexation with modified cyclodextrins: a spectroscopic investigation with implications in the pharmaceutical analysis 85
SPECTROSCOPIC STUDIES ON THE QUERCETIN/(2-HYDROXYPROPYL)-B-CYCLODEXTRIN INTERACTIONS 84
LEAF EXTRACTS OF SOME CORDIA SPECIES - ANALGESIC AND ANTIINFLAMMATORY ACTIVITIES AS WELL AS THEIR CHROMATOGRAPHIC ANALYSIS 84
Stability study of piroxicam and cinnoxicam in solid pharmaceuticals 84
OTTIMIZZAZIONE DI UN METODO ELETTROFORETICO PER L'ANALISI DI ISOFLAVONI E COUMESTANI 84
DETERMINAZIONE DELLA STABILITA' DI PRODOTTI DI INTERESSE FARMACEUTICO. 84
Enantioselective recognition of 2,3-benzodiazepin-4-one derivatives with anticonvulsant activity on several polysaccharide chiral stationary phases 83
PALLADIUM(II) COMPLEXES OF 1,4-BENZODIAZEPINES - CRYSTAL- STRUCTURE AND REACTIVITY IN DIMETHYLSULFOXIDE OF [PD(BROMAZEPAM)CL2] 83
EXPERIMENTAL DESIGN IN THE DEVELOPMENT OF HPLC METHOD FOR THE ASSAY OF GEMCITABINE 83
Totale 11.949
Categoria #
all - tutte 43.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.103


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021206 0 0 0 0 0 0 0 0 0 70 113 23
2021/2022847 2 181 7 13 15 3 65 39 3 111 151 257
2022/20232.102 151 138 100 154 198 197 34 127 903 8 76 16
2023/2024360 54 76 30 39 41 64 6 10 0 17 3 20
2024/20252.183 30 28 41 129 89 57 87 502 551 110 179 380
2025/20265.562 282 348 392 415 502 1.395 816 618 636 158 0 0
Totale 13.662